IP Library Patent Application 18764303
Patent Application
App. No. 18/764,303

HIGH-POTENCY VITAMIN C AND SUGAR ALCOHOL TOPICAL FORMULATIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/764,303
Abstract

Topical formulations of L-ascorbic acid dissolved in a combination of a sugar alcohol agent, and a non-aqueous skin-compatible solvent are provided. The formulations are storage stable for an extended period of time without significant degradation of the L-ascorbic acid in the composition, and have desirable physical properties. The topical formulations can include high concentrations of the L-ascorbic acid. Topical compositions of this disclosure find use in treating or preventing a variety of cosmetic and/or dermatological conditions as well as to reduce the appearance of chronological and/or environmentally-caused skin aging.

Claims (64)

1 . A storage stable topical liquid composition comprising:

a. 10% to 20% by weight ascorbic acid;

b. 5% to 10% by weight of xylitol; and

c. less than 10% by weight in total of one or more optional additional components selected from an antioxidant, a skin lightening agent, a chemical exfoliant, a moisturizing agent, and an anti-inflammatory agent;

d. dissolved in a non-aqueous skin-compatible solvent selected from the group consisting of: 1,3 propanediol, 1,2 propanediol, 1,3 butanediol, 1,5 pentanediol, 1,2 hexanediol, 1,6 hexanediol, glycerol, and a combination thereof,

wherein the composition demonstrates less than 5 mol % degradation of the ascorbic acid after storage for 8 weeks at 40±2° C. in a sealed container.

2 . (canceled)

3 . (canceled)

4 . (canceled)

5 . (canceled)

6 . (canceled)

7 . (canceled)

8 . (canceled)

9 . (canceled)

10 . (canceled)

11 . (canceled)

12 . The composition of claim 1 , wherein the composition comprises 7 to 10% by weight of xylitol.

13 . The composition of claim 1 , wherein the composition comprises 10 to 15% by weight of ascorbic acid.

14 . (canceled)

15 . (canceled)

16 . (canceled)

17 . The composition of any one of claim 1 , wherein the solvent is 1,3 propanediol, or a mixture of 1,3 propanediol and 1,2 hexanediol.

18 . (canceled)

19 . The composition of claim 1 , wherein the composition comprises the one or more additional components.

20 . The composition of claim 19 , wherein the antioxidant comprises ferulic acid.

21 . The composition of claim 19 , wherein the chemical exfoliant comprises is salicylic acid.

22 . The composition of claim 19 , wherein the skin lightening agent comprises azelaic acid.

23 . The composition of claim 19 , wherein the moisturizing agent comprises urea or glycerin.

24 . The composition of claim 19 , wherein the anti-inflammatory agent comprises madecassoside.

25 . The composition of claim 19 , wherein the antioxidant comprises Pinus pinaster bark extract.

26 . The composition of claim 19 , wherein the composition comprises 0.5% salicylic acid.

27 . The composition of claim 19 , wherein the composition comprises 0.5% ferulic acid.

28 . The composition of claim 19 , wherein the composition comprises 5% of azelaic acid.

29 . The composition of claim 19 , wherein the composition comprises 5% of azelaic acid, 0.5% salicylic acid, and 0.5% ferulic acid.

30 . The composition of claim 19 , wherein the composition comprises 0.5% Pinus pinaster bark extract.

31 . (canceled)

32 . (canceled)

33 . (canceled)

34 . (canceled)

35 . The composition of claim 1 , wherein the ascorbic acid is dissolved at a concentration that is above its maximum concentration in the solvent alone.

36 . The composition of claim 1 , wherein the composition comprises:

a. 15% to 20% by weight ascorbic acid;

b. 7% to 10% by weight of xylitol; and

c. less than 10% by weight in total of one or more optional additional components selected from the moisturizing agent urea, the chemical exfoliant salicylic acid, and the antioxidant ferulic acid;

d. dissolved in 1,3 propanediol or 1,2 propanediol.

37 . (canceled)

38 . (canceled)

39 . (canceled)

40 . (canceled)

41 . (canceled)

42 . (canceled)

43 . (canceled)

44 . (canceled)

45 . A ready-to-use topical preparation in a multi-use container which is pre-filled with a storage stable topical composition of claim 1 .

46 . (canceled)

47 . (canceled)

48 . (canceled)

49 . (canceled)

50 . (canceled)

51 . The composition of claim 19 , wherein:

the antioxidant comprises ferulic acid;

the skin lightening agent comprises azelaic acid;

the chemical exfoliant comprises salicylic acid; and

the anti-inflammatory agent comprises madecassoside.

Assignments (3)
ASSET PURCHASE AGREEMENT Recorded Apr 11, 2025
From: ICB (AN ABC), LLC
To: MF BEAUTY PARTNERS LLC
Reel/Frame 070820/0964 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2025
From: BAEK CLINICAL INC.
To: ICB (AN ABC), LLC
Reel/Frame 070781/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2025
From: BAEK, JIHOON P.
To: BAEK CLINICAL INC.
Reel/Frame 070581/0186 →